Indication intelligence, analysis and sector perception

MiMedx Group (MDXG) a BIG broom sweeps all...

July 2, 2018 12:04pm

Reiterating from the pre-open’s newsletter …

Mid-session, MDXG is DOWN -$2.23 or -34.90% to $4.16 after closing (Friday) at $6.39 and opening at $4.67

The Board of Directors of MiMedx Group, Inc. (MDXG) announced that Parker H. "Pete" Petit has resigned from his roles as MDXG's Chairman of the Board and Chief Executive Officer but currently remains a director on the Board.

MiMedx also announced that William C. "Bill" Taylor has resigned as President and Chief Operating Officer and as a member of the MiMedx Board.

These resignations, which follow the recent departures of MDXG's Chief Financial Officer and Corporate Controller and Treasurer, are based on the Board of Directors' business judgment regarding the Company's leadership and direction, and arise, in part, from information the Audit Committee has identified through its previously announced independent investigation.

The MiMedx Board of Directors has named Charles R. Evans, previously the lead independent director, as Chairman of the Board, effective immediately.

The Board has also appointed David Coles to serve as MDXG's interim Chief Executive Officer.

Mr. Coles is a Managing Director with Alvarez & Marsal, a global professional services firm that advises and provides services to companies in areas that include corporate performance improvement, interim management, healthcare and corporate restructurings.

The Board of Directors has commenced a search to identify and evaluate internal and external candidates to serve as permanent CEO.

A TRAIN WRECK …

The internal investigation into MDXG's business practices remains ongoing,

The BOD has concluded that it will need to restate all of its financial statements between fiscal year 2012 and fiscal year 2017,

The BOD told investors that the report from the first quarter of 2018 "should no longer be relied upon,

Guidance for 2018 has been withdrawn,

The SEC and U.S. Department of Justice have issued subpoenas (last year) that need to be respond to and …

It ain’t over until “SOMEONE” goes to JAIL!

This stock is a nuclear hazard - "UNTOUCHEABLE"!

35 companies, 1 interpreter!

Insight, foresight and recommendation

What's Happening Today

8 hours 36 min ago
RegMed Investors’ (RMi) pre-open: It’s “make” a buck day!

My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.

My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.

Do you have an opinion you would like to share with us? We would like to hear from you.

Please e-mail us at hwm@regmedinvestors.com.

Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors with past experience in sell-side analysis, buy-side management, corporate management and due diligence.

RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.

The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.

The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.